Home
/
FENNEC PHARMACEUTICALS INC.
/
Financials
/
Quarterly
FENNEC PHARMACEUTICALS INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that FENNEC PHARMACEUTICALS INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$12.46M
Nov 13, 2025
Q2
2025
Jun 30, 2025
$9.65M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$8.75M
May 14, 2025
Q3
2025
Sep 30, 2024
$6.97M
Nov 13, 2025
Q2
2025
Jun 30, 2024
$7.26M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$25.38M
May 14, 2025
Q3
2024
Sep 30, 2023
$6.52M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$3.33M
Aug 13, 2024
Q1
2024
Mar 31, 2023
$1.68M
May 14, 2024
Q1
2020
Mar 31, 2021
$0
May 13, 2021
Q3
2021
Dec 31, 2020
$200.00M
Nov 10, 2021
Q1
2022
Dec 31, 2020
$200.0K
May 12, 2022
Q2
2022
Dec 31, 2020
$200.0K
Aug 12, 2022
Q3
2020
Sep 30, 2020
$0
Nov 16, 2020
Q2
2020
Jun 30, 2020
$0
Aug 5, 2020
Q1
2020
Mar 31, 2020
$0
May 13, 2021
Q3
2020
Sep 30, 2019
$0
Nov 16, 2020
Q2
2020
Jun 30, 2019
$0
Aug 5, 2020
Q1
2020
Mar 31, 2019
$0
May 14, 2020
Q3
2019
Sep 30, 2018
$0
Nov 12, 2019
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($638.0K)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($3.15M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($3.15M)
Nov 13, 2025
Q2
2025
Mar 31, 2025
($1.17M)
Aug 14, 2025
Q3
2025
Mar 31, 2025
($1.17M)
Nov 13, 2025
Q1
2025
Mar 31, 2025
($1.17M)
May 14, 2025
Q3
2025
Sep 30, 2024
($5.74M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($5.55M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($5.55M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
$12.84M
May 14, 2025
Q2
2025
Mar 31, 2024
$12.84M
Aug 14, 2025
Q3
2025
Mar 31, 2024
$12.84M
Nov 13, 2025
Q3
2024
Sep 30, 2023
($1.87M)
Nov 8, 2024
Q3
2024
Jun 30, 2023
($5.44M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($5.44M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($6.05M)
May 14, 2024
Q2
2024
Mar 31, 2023
($6.05M)
Aug 13, 2024
Q3
2024
Mar 31, 2023
($6.05M)
Nov 8, 2024
Q3
2023
Sep 30, 2022
($8.09M)
Nov 9, 2023
Q3
2023
Jun 30, 2022
($5.07M)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($189.0K)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($2.73M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($808.0K)
May 14, 2025
Q3
2025
Sep 30, 2024
($5.20M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($5.04M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
$13.74M
May 14, 2025
Q3
2024
Sep 30, 2023
($1.02M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($4.67M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($5.27M)
May 14, 2024
Q3
2023
Sep 30, 2022
($7.90M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($5.01M)
Aug 7, 2023
Q1
2023
Mar 31, 2022
($3.55M)
May 12, 2023
Q3
2022
Sep 30, 2021
($4.17M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($3.92M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($4.92M)
May 12, 2022
Q3
2021
Sep 30, 2020
($5.86M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($4.85M)
Aug 10, 2021
Q1
2020
Mar 31, 2020
($3.84M)
May 13, 2021
Q3
2020
Sep 30, 2019
($1.86M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($4.81M)
Aug 5, 2020